In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

A single tool for early detection, accurate staging, and personalized treatment of prostate cancer (PCa) would be a major breakthrough in the field of PCa. Gastrin-releasing peptide receptor (GRPR) targeting peptides are promising probes for a theranostic approach for PCa overexpressing GRPR. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatalic, Kristell L.S., Konijnenberg, Mark, Nonnekens, Julie, de Blois, Erik, Hoeben, Sander, de Ridder, Corrina, Brunel, Luc, Fehrentz, Jean-Alain, Martinez, Jean, van Gent, Dik C., Nock, Berthold A., Maina, Theodosia, van Weerden, Wytske M., de Jong, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679358/
https://www.ncbi.nlm.nih.gov/pubmed/26722377
http://dx.doi.org/10.7150/thno.13580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679358/
https://www.ncbi.nlm.nih.gov/pubmed/26722377
http://dx.doi.org/10.7150/thno.13580

Ejemplares similares